Several reports have revealed that TAMs and CSF-1 are correlated with advanced disease or distant metastasis in conventional GC and cancers of other organs [9, 11–14]; however, no reports have examined the clinical significance of TAMs and CSF-1 in HAS. This evidence concerns the gene CSF1 and cancer.